The Interventional Radiology Products market size was valued at US$ 24,947.01 million in 2022 and is expected to reach US$ 39,363.39 million by 2030; and is projected to witness a CAGR of 5.8% from 2022 to 2030.
Market Insights and Analyst View:
Interventional radiology products are a type of medical imaging technique for guiding doctors to diagnose and treat specific problems related to blood vessels and lymph vessels throughout the body. IR is also called image-guided therapy.
Key factors driving the interventional radiology products market growth are the increasing incidence and prevalence of chronic diseases such as cancer, cardiovascular disease, diabetes, and others. The government has been investing heavily in research and development in the healthcare sector, leading to the development of new and innovative interventional radiology products. However, regulatory hurdles may hinder market growth.
Growth Drivers and Restraints:
Higher adoption of interventional radiology products for cancer detection. The cancer Interventional radiology market refers to the field of medicine that utilizes minimally invasive techniques for diagnosis and treatment of different types of cancer. Interventional radiologists use imaging guidance, such as X-rays, CT scans, or ultrasound, to precisely target tumors and deliver therapies directly to the site of the disease. Additionally, advancements in imaging technology have improved the accuracy and precision of interventional radiology product procedures, allowing for better tumor detection and targeted treatment delivery. These technological advancements, coupled with the growing prevalence of cancer globally, have further fueled the demand for interventional radiology products in cancer management. The market is also driven by the higher adoption of interventional oncology as a multidisciplinary approach in cancer care. Collaboration between interventional radiologists, medical oncologists, and radiation oncologists has resulted in improved patient outcomes and expanded treatment options. Furthermore, the growing preference and research activities for personalized medicine and targeted therapies have contributed to the growth of the cancer interventional radiology products market. Interventional radiologists can deliver localized treatments, such as radiofrequency ablation, chemoembolization, or radioembolization, directly to tumors while minimizing damage to healthy tissues.
One of the secondary factors driving global interventional radiology products is the aging population, which is leading to an increasing prevalence of chronic diseases that require interventional radiology procedures. This has driven the demand for interventional radiology products worldwide. Growing healthcare infrastructure, as many developing countries are investing in improving their healthcare infrastructure, leading to increased adoption of interventional radiology products. Many countries, such as China, have become popular destinations for medical tourism, leading to increased demand for interventional radiology products and services. There is a growing preference for minimally invasive procedures, which has led to an increased demand for interventional radiology products that enable such procedures. Collaboration between healthcare providers and manufacturers, as well as partnerships between different healthcare organizations, have contributed to the growth of the interventional radiology products market. With an increase in healthcare expenditure globally, there is a greater capacity for investment in interventional radiology products and services. As awareness about the benefits of interventional radiology procedures grows, there is an increasing demand for related products and services. These secondary drivers are contributing to the overall growth of the global interventional radiology products market, creating opportunities for manufacturers and healthcare providers worldwide.
Interventional radiology products often require approval from regulatory bodies, which can be time-consuming and costly. Strict regulations can slow down the adoption of new techniques and technologies in this field. Interventional radiology procedures require specialized equipment and training, which can be expensive. This cost can limit the accessibility of these procedures in specific regions or healthcare settings with limited resources. The reimbursement policies for interventional radiology product procedures can vary, making it difficult for healthcare providers to receive adequate payment for their services. This can deter hospitals and clinics from offering these procedures, limiting patient access. The aforementioned factors are expected to hamper market growth to a certain extent.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Interventional Radiology Equipment Market: Strategic Insights
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Interventional Radiology Equipment Market: Strategic Insights
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The global Interventional radiology products Market is categorized on the basis of type, procedure, and application. Based on type, the interventional radiology products market is segmented into catheters, stents, inferior vena cava filters, hemodynamic flow alteration devices, angioplasty balloons, thrombectomy systems, embolization devices, biopsy needles, accessories, and others. Based on procedure, the interventional radiology products market is segmented into angioplasty, angiography, embolization, thrombolysis, biopsy and drainage, vertebroplasty, nephrostomy, and others. Based on application, the interventional radiology products market is segmented into cardiology, urology and nephrology, oncology, gastroenterology, neurology, orthopedics, and others. The Interventional radiology products market, based on geography, is segmented into North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Russia, and the Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Segmental Analysis:
The interventional radiology products market, by type, is segmented into catheters, stents, inferior vena cava filters, hemodynamic flow alteration devices, angioplasty balloons, thrombectomy systems, embolization devices, biopsy needles, accessories, and others. The catheters segment held the largest interventional radiology products market share in 2022, and it is anticipated to register the highest CAGR in the market during 2022-2030. The development of innovative materials and designs that enhance catheter performance, reduce procedure time, and improve patient comfort is expected to drive market expansion. The shift towards value-based healthcare and the emphasis on cost-effective and efficient medical devices are also influencing the demand for radiology catheters. These factors contribute to the growing demand for the catheter-type products segment.
Based on the procedure, the interventional radiology products market is segmented into angioplasty, angiography, embolization, thrombolysis, biopsy and drainage, vertebroplasty, nephrostomy, and others. The angiography intervention radiology products market is experiencing significant growth due to the increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive procedures. Angiography is a key interventional radiology technique used for diagnosing and treating various cardiovascular conditions, such as coronary artery disease, peripheral artery disease, and aneurysms. The aging population and the associated increase in age-related cardiovascular conditions are contributing to the expansion of the angiography intervention radiology products market. The demand for specialized devices for angioplasty, stenting, and embolization procedures is also driving market growth.
Based on the application, the interventional radiology products market is segmented into cardiology, urology and nephrology, oncology, gastroenterology, neurology, orthopedics, and others. The Cardiology segment held the largest interventional radiology products market share in 2022. However, the oncology segment is expected to register the highest CAGR in the market during 2022-2030. The rising demand for minimally invasive procedures in cardiology, such as angioplasty and stent placement, is increasing the need for specialized catheters designed for cardiology procedures. The adoption of innovative catheter technologies, including intravascular ultrasound and fractional flow reserve measurements, is also fueling market expansion for cardiology interventional radiology products.
Interventional Radiology Products Market, by Type – 2022 and 2030
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Regional Analysis:
Based on geography, the global interventional radiology products market is segmented into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. North America is expected to register the highest revenue share in the year 2022. The region is home to several key players in the medical device industry, and it has a well-established healthcare infrastructure that supports the adoption of advanced interventional radiology techniques. The United States is the largest market for intervention radiology products in North America, driven by factors such as the high prevalence of cardiovascular diseases, the presence of major healthcare facilities, and the higher demand for minimally invasive procedures. Additionally, the country has a strong focus on technological innovation and research and development, which further drives market growth. Canada is also a significant market for intervention radiology products, with a growing emphasis on improving patient outcomes and reducing healthcare costs. The country's healthcare system is increasingly adopting advanced interventional radiology techniques, leading to a growing demand for angiography products. Overall, the North American intervention radiology products market is expected to continue experiencing significant growth, driven by factors such as the higher prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures. Manufacturers in the region are majorly focused on developing cutting-edge products to meet the evolving needs of health care providers and patients in the field of interventional radiology.
Asia Pacific is estimated to register the highest CAGR during 2022–2030, owing to an increasing focus on preventive cardiology, with healthcare providers and patients recognizing the importance of early detection and management of cardiovascular risk factors. Overall, the increasing prevalence and incidence of chronic diseases, technological advancements, and the growing demand for minimally invasive procedures are key drivers of the interventional radiology products market. As a result, manufacturers are focusing on developing advanced products to meet the changing needs of healthcare providers and patients in the field of interventional radiology. China's interventional radiology products market is expected to account for the largest market share and revenue in the year 2022, owing to the increasing prevalence and incidence of cardiovascular diseases and other chronic conditions in the country. As the population continues to age and lifestyles change, the demand for interventional radiology procedures, including angiography, is expected to rise. Additionally, the Chinese government has been spending heavily on healthcare infrastructure and technology, leading to the expansion and modernization of medical facilities across the country. This has created a growing market for interventional radiology products as healthcare providers seek to offer advanced treatment options to their patients. Another driver of the interventional radiology market in China is the increasing adoption of minimally invasive procedures. Patients and healthcare providers are increasingly seeking out less invasive treatment procedures that offer faster recovery times and fewer complications. This has led to a growing demand for angiography and other interventional radiology products that support minimally invasive techniques.
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global interventional radiology products market are listed below:
- In January 2023, GE HealthCare acquired IMACTIS. Under this partnership, the company focuses on developing novel computerized tomography (CT) navigation products that will help surgeons with minimally invasive operations and reduce overall procedure time.
- In November 2022, Konica Minolta Healthcare Americas, Inc. launched new digital radiography (DR) solutions that will continue to transform the clinical value of X-ray interventional radiology products.
Competitive Landscape and Key Companies:
Medtronic, Boston Scientific Corporation, Becton Dickinson and Company, Abbott, Cardinal Health, B.Braun Melsungen AG, Stryker, Terumo Medical Corporation, and Biosensors International Group, Ltd. are among the prominent players operating in the interventional radiology products market. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Carestream Health
2. Esaote SPA
3. GE Healthcare
4. Hitachi Medical Corporation
5. Hologic Inc.
6. Koninklijke Philips NV
7. Shimadzu Corporation
8. Siemens Healthineers AG
9. Canon Medical Systems Corporation
10. Samsung Medison (Samsung Electronics Co. Ltd)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Interventional Radiology Equipment Market
Apr 2024
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Apr 2024
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Apr 2024
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)